ROLE OF 400 MCG INTRAOPERATIVE SUBLINGUAL MISOPROSTOL FOR REDUCTION OF CAESAREAN BLOOD LOSS

Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2017, Vol 4, Issue 10

Abstract

BACKGROUND Lower segment caesarean section is a common surgical procedure. Postpartum haemorrhage incidence after LSCS is 4%. Misoprostol is a prostaglandin E1 analogue with good uterotonic properties, easy availability, low cost, thermostability, long shelf life, easy administration and few adverse effects at therapeutic dose. It is readily absorbed by oral, sublingual, buccal, vaginal or rectal route. Sublingual route attains quickest concentration. Dose of 400 mcg was chosen in this study to minimise adverse effects with optimal therapeutic benefit. The aim of the study is to determine the efficacy of sublingual misoprostol in reducing caesarean blood loss. MATERIALS AND METHODS It is a prospective experimental study done in VSSIMSAR, Burla. Women undergoing LSCS were randomly assigned to study and control groups of equal strength of 100 each. In all cases, preoperative Hb%, haematocrit, pulse, BP was noted. Study group were given 400 mcg misoprostol at the time of cord clamping. In control group, nothing was given. In all patients, active management of third stage of labour was done by using oxytocin 10 IU (IV) along with uterine massage. Blood loss soaked by tetra was calculated using formula, blood loss = wet weight-dry weight/1.05 (1.05 is constant). Amount of blood loss, postoperative Hb%, haematocrit, pulse rate, BP was noted in both groups and compared. BP and pulse were noted after 1 hour and Hb%, haematocrit were noted after 24 hours. RESULTS Study group showed significant decrease in total blood loss (around 117.9 mL) as compared to control group. There was significant decrease in the postoperative fall in Hb in the study group as compared to control, the mean difference being 0.631 gm%. Study group also showed decrease in postoperative fall in haematocrit as compared to control, the mean difference being 0.055. CONCLUSION Misoprostol significantly reduced caesarean blood loss and doesn’t affect foetal outcome without significant adverse effect.

Authors and Affiliations

Lalmohan Nayak, Kumudini Pradhan, Satyjeet Mishra

Keywords

Related Articles

HRCT THORAX FINDINGS OF INFLUENZA A H1N1 PNEUMONIA IN A TERTIARY CARE HOSPITAL IN SOUTH INDIA

BACKGROUND Influenza viruses are common seasonal pathogens affecting the human respiratory system. H1N1 pneumonia (swine flu) is a highly contagious respiratory disease caused by one of the several swine flu influenza A...

A STUDY ON LENS-INDUCED GLAUCOMA

BACKGROUND A study on factors in lens responsible, duration, time of interference and management of increased IOP in lens-induced glaucoma and estimation of aqueous protein level in lens-induced glaucoma. MATERIALS AND M...

REFRACTIVE ERRORS IN SCHOOL CHILDREN IN URBAN AND RURAL AREAS OF LUDHIANA, PUNJAB

BACKGROUND Refractive errors are the second most common cause for childhood blindness across the globe. Early detection and correction of refractive errors in school children is inexpensive and also an effective form of...

IS THERE AN ASSOCIATION BETWEEN RENAL RESISTANCE INDEX AND EARLY POST RENAL TRANSPLANT FUNCTION?

BACKGROUND The Intrarenal Resistance Index (RI) measured by colour Doppler ultrasound early after renal transplant period is to assess renal allograft function, although significance of resistive index remains unclear. H...

A STUDY OF CLINICAL PROFILE OF PATIENTS WITH PLASMODIUM VIVAX MALARIA

BACKGROUND AND AIM OF THE STUDY: Malaria remains one of the major health problems in the tropics with increased morbidity & mortality. Although Plasmodium falciparum has been commonly implicated as the cause of complicat...

Download PDF file
  • EP ID EP213752
  • DOI 10.18410/jebmh/2017/112
  • Views 71
  • Downloads 0

How To Cite

Lalmohan Nayak, Kumudini Pradhan, Satyjeet Mishra (2017). ROLE OF 400 MCG INTRAOPERATIVE SUBLINGUAL MISOPROSTOL FOR REDUCTION OF CAESAREAN BLOOD LOSS. Journal of Evidence Based Medicine and Healthcare, 4(10), 573-577. https://europub.co.uk/articles/-A-213752